Bioactive Materials (Dec 2021)

Novel dental implant modifications with two-staged double benefits for preventing infection and promoting osseointegration in vivo and in vitro

  • Xiaoyu Huang,
  • Yang Ge,
  • Bina Yang,
  • Qi Han,
  • Wen Zhou,
  • Jingou Liang,
  • Mingyun Li,
  • Xian Peng,
  • Biao Ren,
  • Bangcheng Yang,
  • Michael D. Weir,
  • Qiang Guo,
  • Haohao Wang,
  • Xinxuan Zhou,
  • Xugang Lu,
  • Thomas W. Oates,
  • Hockin H.K. Xu,
  • Dongmei Deng,
  • Xuedong Zhou,
  • Lei Cheng

Journal volume & issue
Vol. 6, no. 12
pp. 4568 – 4579

Abstract

Read online

Peri-implantitis are a major problem causing implant failure these days. Accordingly, anti-infection during the early stage and subsequent promotion of osseointegration are two main key factors to solve this issue. Micro-arc oxidation (MAO) treatment is a way to form an oxidation film on the surface of metallic materials. The method shows good osteogenic properties but weak antibacterial effect. Therefore, we developed combined strategies to combat severe peri-implantitis, which included the use of a novel compound, PD, comprising dendrimers poly(amidoamine) (PAMAM) loading dimethylaminododecyl methacrylate (DMADDM) as well as MAO treatment. Here, we explored the chemical properties of the novel compound PD, and proved that this compound was successfully synthesized, with the loading efficiency and encapsulation efficiency of 23.91% and 31.42%, respectively. We further report the two-stage double benefits capability of PD + MAO: (1) in the first stage, PD + MAO could decrease the adherence and development of biofilms by releasing DMADDM in the highly infected first stage after implant surgery both in vitro and in vivo; (2) in the second stage, PD + MAO indicated mighty anti-infection and osteoconductive characteristics in a rat model of peri-implantitis in vivo. This study first reports the two-staged, double benefits of PD + MAO, and demonstrates its potential in clinical applications for inhibiting peri-implantitis, especially in patients with severe infection risk.

Keywords